Cargando…
Nodo-paranodopathies: Concepts, Clinical Implications, and Management
Peripheral neuropathies are traditionally categorized into demyelinating or axonal. It has been proposed that dysfunction at nodal/paranodal region may be a key for better understanding of pathophysiology in patients with immune mediated neuropathies. In last few years, antibodies targeting node and...
Autores principales: | Khadilkar, Satish V., Kamat, Saurabh, Patel, Riddhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996523/ https://www.ncbi.nlm.nih.gov/pubmed/36911467 http://dx.doi.org/10.4103/aian.aian_382_22 |
Ejemplares similares
-
Diabetes Mellitus Is a Possible Risk Factor for Nodo-paranodopathy With Antiparanodal Autoantibodies
por: Appeltshauser, Luise, et al.
Publicado: (2022) -
COVID 19: Neuromuscular Manifestations
por: Benny, Rajesh, et al.
Publicado: (2020) -
What is New in Idiopathic Inflammatory Myopathies: Mechanisms and Therapies
por: Khadilkar, Satish V., et al.
Publicado: (2020) -
Current Concepts in the Management of Idiopathic Generalized Epilepsies
por: Rathore, Chaturbhuj, et al.
Publicado: (2022) -
Anti-pan-neurofascin IgM in COVID-19-related Guillain-Barré syndrome: Evidence for a nodo-paranodopathy
por: Tard, Céline, et al.
Publicado: (2020)